Skip to main content
. 2020 Dec 27;12(12):1299–1313. doi: 10.4254/wjh.v12.i12.1299

Table 5.

Changes in quality of life

Control (n = 21)
P value
Intervention (n = 22)
P value
Baseline
Final

Baseline
Final

CLDQ questionnaire
Abdominal symptoms 5.4 ± 1.3 5.2 ± 0.8 0.592 5.0 ± 1.5 5.1 ± 1.2 0.982
Fatigue 4.7 ± 1.1 5.2 ± 0.8 0.063 4.2 ± 1.2 5.1 ± 1.2 0.000
Systemic symptoms 5.6 ± 1.0 5.6 ± 0.9 0.892 4.3 ± 1.2 5.0 ± 0.9 0.002
Activity 5.3 ± 1.2 5.3 ± 1.3 0.892 4.8 ± 1.2 5.5 ± 1.2 0.028
Emotional function 4.9 ± 0.9 5.3 ± 1.1 0.056 4.3 ± 1.3 5.3 ± 1.0 0.000
Worry 5.1 ± 1.1 5.3 ± 1.1 0.521 4.3 ± 1.8 5.2 ± 1.8 0.002
CLDQ overall score 5.2 ± 0.8 5.4 ± 0.9 0.204 4.6 ± 1.0 5.3 ± 0.8 0.001
SF-36 questionnaire
Physical function 80 (70-90) 95 (80-95) 0.005 72.5 (65-95) 87.5 (70-95) 0.007
Physical role 75 (25-100) 100 (50-100) 0.166 62.5 (25 -100) 75 (25-100) 0.468
Body pain 84 (66-90) 84 (72-90) 0.341 78 (61-84) 78 (60-84) 0.725
General health 40 (37-47) 47 (35-52) 0.044 40 (25-55) 42 (32-52) 0.375
Vitality 65 (50-70) 70 (60-75) 0.453 62.5 (50-75) 70 (50-80) 0.037
Social function 100 (75-100) 88 (75-100) 0.875 75 (63-100) 88 (75-100) 0.080
Emotional role 67 (33-83) 67 (33-67) 0.972 67 (33-72) 67 (33-67) 0.752
Mental health 72 (68-84) 84 (64-88) 0.868 76 (64-84) 82 (68-92) 0.073

Data reported as mean ± standard deviation, or median (p25-p75), according to the distribution of the data. CLDQ: Chronic liver disease questionnaire; SF-36: 36-item short form health survey.